Abstract
Medication non-adherence is a common and costly problem. EU-wide, non-adherence may lead to almost 200,000 deaths and excess cost of €80–125 billion. Atrial fibrillation (AF) is the most frequent cardiac arrhythmia, increasing the risk of stroke from three to fivefold and being a leading cause of cerebrovascular mortality and morbidity. Oral anticoagulant medication is recommended to reduce this risk, but medication non-adherence leads to considerable health-risks and avoidable cost.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
